PFIZER INC Quarterly Amortization of Intangible Assets in USD from Q1 2010 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Pfizer Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2010 to Q1 2024.
- Pfizer Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $1.3B.
- Pfizer Inc annual Amortization of Intangible Assets for 2023 was $4.7B, a 30.6% increase from 2022.
- Pfizer Inc annual Amortization of Intangible Assets for 2022 was $3.6B, a 2.7% decline from 2021.
- Pfizer Inc annual Amortization of Intangible Assets for 2021 was $3.7B, a 8.82% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)